Results 271 to 280 of about 5,492,450 (303)

Drug-resistant and extensively drug-resistant tuberculosis in southern Africa

Current Opinion in Pulmonary Medicine, 2010
Drug-resistant tuberculosis (TB) is of increasing global concern. One of the hardest hit regions is southern Africa. This study focuses on a concise update on recently published developments in the field.There is mounting evidence from high-coprevalence areas that the TB and HIV pandemics must be viewed as an entity and tackled together.
openaire   +3 more sources

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

The Lancet Infectious Diseases, 2010
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally thought to have high mortality rates. However, many cases can be treated with the right combination and rational use of available antituberculosis drugs. This Review describes the evidence available for each drug and discusses the basis for recommendations for the
José A, Caminero, Giovanni, Sotgiu, Alimuddin, Zumla, Giovanni Battista, Migliori   +3 more
openaire   +2 more sources

Multidrug-resistant and extensively drug-resistant tuberculosis: a review

Current Opinion in Infectious Diseases, 2008
The spread of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) is a major medical and public health concern for the world. These two forms of highly drug-resistant TB threaten to make TB into an untreatable and highly fatal disease, particularly in resource-poor countries with a high prevalence of AIDS.
Edward D, Chan, Michael D, Iseman
openaire   +2 more sources

Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis

Annals of Internal Medicine, 2009
About 40 000 cases of extensively drug-resistant tuberculosis emerge worldwide annually, but the predictors of extensive drug resistance are unclear.To identify risk factors for extensively drug-resistant tuberculosis and multidrug-resistant but non-extensively drug-resistant tuberculosis in patients with culture-confirmed pulmonary tuberculosis.Cross ...
Kai, Kliiman, Alan, Altraja
openaire   +2 more sources

Extensively Drug-Resistant Tuberculosis

2014
It has been many years since a single agent was recommended for treatment of active tuberculosis (TB). Despite this, there is strong evidence that multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are present in all regions of the world, and there is also evidence that the incidence of drug-resistant forms of TB is increasing ...
openaire   +1 more source

Treatment of extensively drug-resistant tuberculosis

The Lancet, 2009
Deepak, Aggarwal, Prasanta R, Mohapatra, Ashok K, Janmeja   +2 more
openaire   +2 more sources

Linezolid for Extensively Drug-Resistant Tuberculosis

New England Journal of Medicine, 2013
Ernesto, Jaramillo, Karin, Weyer, Mario, Raviglione   +2 more
openaire   +4 more sources

Extensive Drug Resistance of Strong Biofilm-Producing Acinetobacter baumannii Strains Isolated from Infections and Colonization Hospitalized Patients in Southern Poland

Pathogens, 2023
Agnieszka Chmielarczyk, Estera Jachowicz-Matczak, Jadwiga Wójkowska-Mach   +2 more
exaly  

Management of extensively drug-resistant tuberculosis

The Lancet Respiratory Medicine, 2017
Centis, Rosella, SOTGIU, Giovanni, Migliori, Giovanni Battista   +2 more
openaire   +3 more sources

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila Nanayakkara, David E Greenberg
exaly